Abstract
Impaired gene expression is associated with a variety of liver diseases, including hereditary metabolic disorders, viral hepatitis, liver cirrhosis and hepatocellular carcinoma. Gene therapy promises to significantly change the treatment of those intractable liver disorders through the development of new modalities of gene engineering and effective gene delivery systems in combination with better understanding of the biology of the target diseases. This article reviews the present status of gene therapy targeting liver diseases.
